Your investment team at Titan is closely assessing the effects of the recently-detected Omicron variant on your portfolio holdings.
While we are cautious about the variant’s potential impact on markets and on global health, we remain confident in our long-term strategies across Flagship, Opportunities, Offshore, and Crypto—including our recent moves to expand Titan clients’ exposure in the healthcare sector. We’re doing our due diligence and will adjust the portfolios appropriately, if needed.
As always, we’ll keep you fully informed on any trades and our reasoning behind them. In times of volatility and uncertainty, we strive to be your steady and reliable investment team. We are honored to do the hard research and assessments on your portfolios, so that you can focus your energy and attention on what matters most.
If you have any questions, you can contact us via the Titan app. We’re only a message away.